Edition:
United Kingdom

Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,525.50GBp
2:51pm BST
Change (% chg)

30.00 (+0.67%)
Prev Close
4,495.50
Open
4,504.50
Day's High
4,545.00
Day's Low
4,504.50
Volume
819,508
Avg. Vol
2,146,200
52-wk High
4,576.00
52-wk Low
2,940.50

Select another date:

Fri, Sep 14 2018

UPDATE 1-FTSE tracks Europe higher; Shire shines

MILAN, Sept 14 Britain's top share index tracked higher European markets on Friday with the mood buoyed by easing trade worries, while Shire rose after China cleared Takeda's plans to buy the drugmaker.

FTSE tracks Europe higher on trade hopes; Shire shines

MILAN, Sept 14 Britain's top share index tracked higher European markets on Friday with the mood buoyed by easing trade worries, while Shire rose after China cleared Takeda's plans to buy the drugmaker.

Takeda gets China's approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Friday China approved its purchase of Shire Plc, the latest regulator to clear the $62 billion deal and bring the Japanese group closer to becoming a global top 10 drugmaker.

Takeda gets China's approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Friday China approved its purchase of Shire Plc , the latest regulator to clear the $62 billion (47 billion pounds) deal and bring the Japanese group closer to becoming a global top 10 drugmaker.

UPDATE 1-Takeda gets China's approval for $62 bln Shire purchase

* Takeda still awaiting approval from EU, Japan (Adds background, share price)

Takeda gets China's approval for $62 bln Shire purchase

Sept 14 Japan's Takeda Pharmaceutical Co Ltd said on Friday China's market regulator had approved its $62 billion acquisition of Shire Plc, bringing it closer to becoming a global top 10 drugmaker.

Takeda weighs sale of Shire's eye care business to cut debt: Bloomberg

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday.

Takeda weighs sale of Shire's eye care business to cut debt - Bloomberg

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion (47 billion pounds) purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday.

Takeda weighs sale of Shire's eye care business to cut debt- Bloomberg

Sept 13 Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday.

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the closing of its Shire Plc acquisition.

Select another date: